The safety of blinatumomab in pediatric patients with acute lymphoblastic leukemia: A systematic review and meta-analysis

• Main Authors: Maria Maddalena Marrapodi (Author), Annamaria Mascolo (Author), Gabriella di Mauro (Author), Gianluca Mondillo (Author), Elvira Pota (Author), Francesca Rossi (Author)
• Formato: Libro
• Publicado: Frontiers Media S.A., 2022-07-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

BackgroundBlinatumomab is a bispecific CD19-directed CD3 T-cell engager that has proven efficacy in children with relapsed or refractory B-cell acute lymphoblastic leukemia (ALL). Despite its efficacy, it has also been associated with the development of potentially serious adverse events such as the...